“So as you look out to the second-half of this year, our expectation, it continues at those levels that we've been seeing with the -- I mentioned a few 100 basis points above our expectations in the senior business, that continues.”

In context

“R to be a little bit lower in the 3Q than we saw in the 2Q, some of that seasonality, as you would fully expect. So within the contexting of balance, expect earnings to be a little bit higher marginally in 3Q than 4Q, because of that typical factor in there, and thinking of an MCR somewhere in the zone of between, kind of, what we saw in the 1Q and 2Q just by seasonality factor. Important in that is we expect the, kind of, general pacing of care activity to remain consistent. That's what we've actually been seeing here. So since we've talked about this and as we've looked at the level of care activity across the company, these elements we talked about in terms of senior outpatient care are really remaining stable at the levels we talk to. And our expectation is it continues in that level. So as you look out to the second-half of this year, our expectation, it continues at those levels that we've been seeing with the -- I mentioned a few 100 basis points above our expectations in the senior business, that continues. The only underlying factor is a little bit of seasonality that you would see occurring there. Andrew Witty: Right. Thanks so much John and thanks Nate. Next question. Operator: We’ll go next to Justin Lake with Wolfe Research. Justin Lake: Thanks, good morning. My question is on commercial trend. That you mentioned it's in line with expectations. I wanted to delve a little bit deeper. I think you might have said previously that you'd priced for commercial trend to be above normal this year, so some conservatism. So does that mean that it's running above normal, but in line with your pricing at this point? If it's above normal, can you tell us how Q2 emerged versus Q4, Q1, meaning that an uptick versus -- in 2Q versus 1Q or 4Q? And then just lastly, any insight on the commercial components”